These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15560954)

  • 1. Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics.
    Sharma RP
    Schizophr Res; 2005 Jan; 72(2-3):79-90. PubMed ID: 15560954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia.
    Dong E; Agis-Balboa RC; Simonini MV; Grayson DR; Costa E; Guidotti A
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12578-83. PubMed ID: 16113080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic downregulation of GABAergic function in schizophrenia: potential for pharmacological intervention?
    Costa E; Grayson DR; Guidotti A
    Mol Interv; 2003 Jun; 3(4):220-9. PubMed ID: 14993449
    [No Abstract]   [Full Text] [Related]  

  • 4. [Epigenetic model in the pharmacologic modulation of vulnerability to schizophrenia].
    Tremolizzo L
    Encephale; 2007 Nov; 33(Pt 3):867-9. PubMed ID: 18402359
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling.
    Guidotti A; Dong E; Kundakovic M; Satta R; Grayson DR; Costa E
    Trends Pharmacol Sci; 2009 Feb; 30(2):55-60. PubMed ID: 19110320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability.
    Tremolizzo L; Carboni G; Ruzicka WB; Mitchell CP; Sugaya I; Tueting P; Sharma R; Grayson DR; Costa E; Guidotti A
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17095-100. PubMed ID: 12481028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia.
    Grayson DR; Chen Y; Costa E; Dong E; Guidotti A; Kundakovic M; Sharma RP
    Pharmacol Ther; 2006 Jul; 111(1):272-86. PubMed ID: 16574235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking epigenetics to lipid metabolism: focus on histone deacetylases.
    Ferrari A; Fiorino E; Giudici M; Gilardi F; Galmozzi A; Mitro N; Cermenati G; Godio C; Caruso D; De Fabiani E; Crestani M
    Mol Membr Biol; 2012 Nov; 29(7):257-66. PubMed ID: 23095054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABAergic promoter hypermethylation as a model to study the neurochemistry of schizophrenia vulnerability.
    Costa E; Chen Y; Dong E; Grayson DR; Kundakovic M; Maloku E; Ruzicka W; Satta R; Veldic M; Zhubi A; Guidotti A
    Expert Rev Neurother; 2009 Jan; 9(1):87-98. PubMed ID: 19102671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together?
    Geiman TM; Robertson KD
    J Cell Biochem; 2002; 87(2):117-25. PubMed ID: 12244565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic mechanisms in schizophrenia.
    Roth TL; Lubin FD; Sodhi M; Kleinman JE
    Biochim Biophys Acta; 2009 Sep; 1790(9):869-77. PubMed ID: 19559755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
    Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
    Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid receptors in health and disease: co-regulators and the chromatin connection.
    Minucci S; Pelicci PG
    Semin Cell Dev Biol; 1999 Apr; 10(2):215-25. PubMed ID: 10441075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability.
    Costa E; Grayson DR; Mitchell CP; Tremolizzo L; Veldic M; Guidotti A
    Crit Rev Neurobiol; 2003; 15(2):121-42. PubMed ID: 14977367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice.
    Tremolizzo L; Doueiri MS; Dong E; Grayson DR; Davis J; Pinna G; Tueting P; Rodriguez-Menendez V; Costa E; Guidotti A
    Biol Psychiatry; 2005 Mar; 57(5):500-9. PubMed ID: 15737665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Update on epigenetic regulation in pathophysiologies of stress-induced psychiatric disorders].
    Miyagawa K; Tsuji M; Fujimori K; Takeda H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Aug; 30(4):153-60. PubMed ID: 20857692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics of psychoactive drugs.
    Boyadjieva N; Varadinova M
    J Pharm Pharmacol; 2012 Oct; 64(10):1349-58. PubMed ID: 22943166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic mechanisms in schizophrenia.
    Shorter KR; Miller BH
    Prog Biophys Mol Biol; 2015 Jul; 118(1-2):1-7. PubMed ID: 25958205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia.
    Akbarian S; Ruehl MG; Bliven E; Luiz LA; Peranelli AC; Baker SP; Roberts RC; Bunney WE; Conley RC; Jones EG; Tamminga CA; Guo Y
    Arch Gen Psychiatry; 2005 Aug; 62(8):829-40. PubMed ID: 16061760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation and chromatin - unraveling the tangled web.
    Robertson KD
    Oncogene; 2002 Aug; 21(35):5361-79. PubMed ID: 12154399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.